Molecular Vision: Tanaka, Mol Vis 2011; 17:2751-2758. Table 3

Table 3. Logistic regression analysis with adjustment for confounding factors.

	Total AMD patients			nAMD			PCV			RAP
Susceptibility genotype	p-value	OR	95%CI	p-value	OR	95%CI	p-value	OR	95%CI	p-value	OR	95%CI
rs800292 (CFH)
GG (rec)	2.36×10⁻⁸	2.47	1.79–3.41	7.66×10⁻⁸	2.90	1.96–4.27	1.42×10⁻⁵	2.26	1.55–3.27	0.029	2.09	1.08–4.06
GG+GA (dom)	3.33×10⁻⁴	2.71	1.57–4.67	6.22×10⁻³	2.68	1.32–5.34	8.46×10⁻³	2.32	1.23–4.39
rs10490924 (ARMS2)
GT+TT (dom)	3.85×10⁻⁶	2.29	1.61–3.26	2.00×10⁻⁵	2.59	1.67–4.02	5.88×10⁻³	1.75	1.17–2.62	0.001	11.60	2.69–50.03
TT (rec)	2.37×10⁻¹⁹	5.74	3.76–8.77	3.24×10⁻¹⁶	7.03	4.40–11.23	1.54×10⁻⁶	3.37	2.09–5.42	1.54×10⁻¹³	22.18	9.74–50.50
rs2301995 (ELN)
CC (rec)				2.2×10⁻²	1.58	1.07–2.35
CC+CT (dom)
rs1801133 (MTHFR)
CC (rec)				2.50×10⁻³	1.82	1.23–2.68
CC+CT (dom)

Logistic regression analysis was performed for each genotype with adjustment for confounding factors (age, gender, hypertension, diabetes mellitus and smoking). Abbreviations: AMD represents age-related macular degeneration, nAMD represents neovascular age-related macular degeneration, PCV represents polypoidal choroidal vasculopathy, RAP represents retinal angiomatous proliferation, CI represents confidence intervals, dom represents dominant model, rec represents recessive model. p-values for comparisons between the case and control groups. p-values for genotypes were calculated using Fisher's exact test. p<0.05. Blanks indicate no siginificant difference.